Solid-State NMR of Viral Fusion Peptides and Proteins

病毒融合肽和蛋白质的固态核磁共振

• 批准号: 8605492
• 负责人: David P Weliky
• 金额: $ 32.67万
• 依托单位: MICHIGAN STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-02-01 至 2016-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8605492
• 关键词: Abbreviations; Adopted; Antigens; Antiviral Agents; Binding; Biochemical; Biological Models; C-terminal; Catalysis; Cell Nucleus; Cell fusion; Cell membrane; Cells; Chemicals; Chimeric Proteins; Cholesterol; DC-specific ICAM-3 grabbing nonintegrin; Data; Data Analyses; Development; Disease; Electron Microscopy; Epitopes; Free Energy; Freeze Fracturing; Funding; Goals; Grant; HIV; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; HIV vaccine; Hemagglutinin; Infection; Label; Left; Length; Lipids; Location; Measurement; Membrane; Membrane Fusion; Modeling; Molecular Conformation; N-terminal; Nuclear Magnetic Resonance; Peptides; Pharmaceutical Preparations; Play; Point Mutation; Production; Proteins; Registries; Research; Resistance development; Resolution; Site; Solid; Structural Models; Structure; T-20; Tertiary Protein Structure; Testing; Therapeutic; Transmembrane Domain; Vertebral column; Vesicle; Viral; Viral Fusion Proteins; Viral Proteins; Viral Vaccines; Virion; Virus; base; cost; design; human disease; influenzavirus; inhibitor/antagonist; insight; neutralizing antibody; peptide structure; protein aminoacid sequence; prototype; public health relevance; receptor; research study; solid state nuclear magnetic resonance; vaccine development

DESCRIPTION (provided by applicant): The long-term goal of the proposed research is to understand the basis for viral fusion protein-induced membrane fusion with atomic-resolution detail. Fusion of viral and target cell membranes is a key step in infection for many viruses important in disease and a detailed understanding of fusion mechanisms will aid development of anti-viral therapeutics whose mode of action is fusion inhibition. Fusion proteins are also a target of viral vaccine development. The proposed research focuses on the gp41 and the hemagglutinin HA2 fusion proteins of the respective human immunodeficiency virus and influenza virus. These proteins are chosen because the viruses cause major human diseases and because the proteins serve as prototypes for other class I viral fusion proteins. There is particular emphasis on the N-terminal "fusion peptide" (FP) domains of the fusion proteins, which represent ~20-residue apolar regions at the N-termini of the proteins. Numerous biochemical and biophysical studies have shown that the FP plays a key role in fusion and that chemically synthesized peptides with the FP sequence can serve as useful model systems to understand some aspects of viral/target cell fusion. The long-term objectives will be achieved with three specific aims. Aim 1 focuses on production of multi-mg quantities of large constructs of gp41 and HA2 proteins that contain FPs, including full-length HA2. In addition, gp41 constructs will be made which contain the C-terminal membrane-proximal external region (MPER) and viral transmembrane (TM) domains. MPER and TM are important in fusion and MPER is also an HIV vaccine target. Residue-specific conformation of the membrane-associated constructs will be determined with solid- state nuclear magnetic resonance (SSNMR) measurements of specific carbonyl (13CO) chemical shifts. There will be particular focus on: (1) testing whether structural models of FP and MPER from short peptide studies are valid for these regions in the large constructs; (2) correlating FP and MPER structure to the observed fusogenicity of the construct; and (3) examining whether the gp41 FP is close to either the MPER or TM. Occlusion of MPER by FP could reduce MPER efficacy as an immunogen. Aim 2 focuses on determining the membrane locations of FP, MPER, and TM regions in these large gp41 and HA2 constructs using SSNMR measurements of distances between protein 13CO and lipid or cholesterol 31P, 19F, or 2H. These experiments will test the general structure-function model that deep but not transmembrane FP membrane insertion correlates with greater membrane perturbation and more rapid fusion catalysis. Aim 3 focuses on determining the distribution of antiparallel registries of b sheet FP in several gp41 constructs with very different FP membrane locations and fusogenicities. The free energies of FP membrane insertion will be estimated for the observed registries and correlated with membrane locations and fusogenicities. The overall goal is to connect high-resolution FP structure, membrane insertion depth, and fusogenicity.

描述(由申请人提供)：拟议研究的长期目标是了解病毒融合蛋白诱导的膜融合的基础和原子分辨率的细节。病毒和靶细胞膜的融合是许多疾病中重要病毒感染的关键步骤，对融合机制的详细了解将有助于以融合抑制为作用模式的抗病毒治疗的发展。融合蛋白也是病毒疫苗开发的目标。建议的研究重点是人类免疫缺陷病毒和流感病毒各自的gp41和血凝素HA2融合蛋白。之所以选择这些蛋白质，是因为这些病毒会导致人类重大疾病，也是因为这些蛋白质是其他I类病毒融合蛋白的原型。尤其是融合蛋白的N-末端“融合肽”(FP)结构域，它代表了蛋白质N-末端的~20个残基的非极区。大量的生化和生物物理研究表明，FP在融合中起着关键作用，化学合成的带有FP序列的多肽可以作为有用的模型系统来理解病毒/靶细胞融合的某些方面。长期目标将通过三个具体目标来实现。目的1专注于生产多毫克量的含有FP的gp41和HA2大结构蛋白，包括全长HA2。此外，还将构建包含C-端膜近端外区(MPER)和病毒跨膜(TM)结构域的gp41。MPER和TM在融合过程中很重要，MPER也是HIV疫苗的靶点。膜相关结构的特定残基构象将通过固体核磁共振(SS核磁共振)测量特定的羰基(13CO)化学位移来确定。将特别关注：(1)测试来自短肽研究的FP和MPER的结构模型是否适用于大型构建体中的这些区域；(2)将FP和MPER结构与观察到的构建体的融合性相关联；以及(3)检查gp41 FP是否接近MPER或TM。FP封闭MPER可降低MPER作为免疫原的效力。目的2通过SS核磁共振测量蛋白质13CO与脂类或胆固醇31P、19F或2H之间的距离，确定FP、MPER和TM区在这些大的gp41和HA2结构中的膜位置。这些实验将检验一般的结构-功能模型，即深而不是跨膜的FP膜插入与更大的膜扰动和更快的融合催化相关。目的3重点研究不同FP膜位置和融合特性的gp41结构中b折叠FP的反平行注册区的分布。FP膜插入的自由能将被估计为观察到的注册表，并与膜位置和融合性相关联。总体目标是连接高分辨率的FP结构、膜插入深度和融合性。